Biodegradable Synthetic Polymer-Based Nano-Drug Delivery Systems and Their Applications in Ophthalmic Disease Treatment

被引:2
作者
Luo, Yang [1 ]
Yang, Lu [2 ]
Feng, Peipei [1 ]
Qiu, Haofeng [1 ]
Wu, Xujin [1 ]
Zhou, Mi [1 ]
Xu, Long [3 ]
Zhu, Yabin [1 ]
机构
[1] Ningbo Univ, Sch Sch, Ningbo 315211, Zhejiang, Peoples R China
[2] Ningbo Univ, Affiliated Hosp, Med Sch, Ningbo 315000, Zhejiang, Peoples R China
[3] Ningbo Univ, Sch Mat Sci & Chem Engn, Ningbo 315211, Zhejiang, Peoples R China
基金
美国国家科学基金会;
关键词
Drug Delivery System; Nanoparticles; Preparation; Treatment; Ocular Diseases; RETINAL-PIGMENT EPITHELIUM; UNFOLDED PROTEIN RESPONSE; IN-VITRO; PLGA NANOPARTICLES; CO-DELIVERY; PROLIFERATIVE VITREORETINOPATHY; MUCOADHESIVE MICROPARTICLES; TRIAMCINOLONE ACETONIDE; CURCUMIN NANOPARTICLES; LOADED NANOPARTICLES;
D O I
10.1166/nnl.2020.3158
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Eye drops is the simplest and least invasive way to deliver drugs to ocular tissues and similar to 90% of the commercial products in the global eye medicine market are administered in this way. Nevertheless, topical application of drug molecules has low bioavailability, which greatly limits its efficacy in the eye. Drug delivery systems on the nanometer scale can effectively improve the bioavailability of drugs administered to the eye and reduce the occurrence of complications owing to their strong penetration, sustained drug release, and the reduced frequency of administration required. These Nano-drug delivery systems can be made into eye drops, injections, dry tablets, implants, gels and in situ gels. Most of the Nano-drug delivery systems have been developed using biodegradable synthetic polymers. Biodegradable synthetic polymers have been widely used as carriers in delivery systems because of their biocompatibility, absorbability, and suitable degradation rate. This article reviews the preparation and performance of nanometer drug delivery systems based on biodegradable synthetic polymers and their applications in the treatment of ocular diseases. Furthermore, we also focus on the potential challenges to the application of nanometer drug delivery systems for ocular diseases.
引用
收藏
页码:575 / 595
页数:21
相关论文
共 211 条
[1]   Cutting Edge Protein and Carbohydrate-Based Materials for Anticancer Drug Delivery [J].
Ahmad, Rasheed ;
Deng, Yan ;
Singh, Ravina ;
Hussain, Mubashir ;
Shah, Muhammad Ali Abdullah ;
Elingarami, Sauli ;
He, Nongyue ;
Sun, Yueming .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2018, 14 (01) :20-43
[2]   5-S-GAD, a novel radical scavenging compound, prevents lens opacity development [J].
Akiyama, Nobuko ;
Umeda, Izumi O. ;
Sogo, Shunji ;
Nishigori, Hideo ;
Tsujimoto, Masafumi ;
Natori, Shunji .
FREE RADICAL BIOLOGY AND MEDICINE, 2009, 46 (04) :511-519
[3]  
Aliautdin R N, 2014, Vestn Oftalmol, V130, P117
[4]   Employing a PLGA-TPGS based nanoparticle to improve the ocular delivery of Acyclovir [J].
Alkholief, Musaed ;
Albasit, Hammam ;
Alhowyan, Adel ;
Alshehri, Sultan ;
Raish, Mohammad ;
Abul Kalam, Mohd ;
Alshamsan, Aws .
SAUDI PHARMACEUTICAL JOURNAL, 2019, 27 (02) :293-302
[5]   Corneal avascularity is due to soluble VEGF receptor-1 [J].
Ambati, Balamurali K. ;
Nozaki, Miho ;
Singh, Nirbhai ;
Takeda, Atsunobu ;
Jani, Pooja D. ;
Suthar, Tushar ;
Albuquerque, Romulo J. C. ;
Richter, Elizabeth ;
Sakurai, Eiji ;
Newcomb, Michael T. ;
Kleinman, Mark E. ;
Caldwell, Ruth B. ;
Lin, Qing ;
Ogura, Yuichiro ;
Orecchia, Angela ;
Samuelson, Don A. ;
Agnew, Dalen W. ;
St. Leger, Judy ;
Green, W. Richard ;
Mahasreshti, Parameshwar J. ;
Curiel, David T. ;
Kwan, Donna ;
Marsh, Helene ;
Ikeda, Sakae ;
Leiper, Lucy J. ;
Collinson, J. Martin ;
Bogdanovich, Sasha ;
Khurana, Tejvir S. ;
Shibuya, Masabumi ;
Baldwin, Megan E. ;
Ferrara, Napoleone ;
Gerber, Hans-Peter ;
De Falco, Sandro ;
Witta, Jassir ;
Baffi, Judit Z. ;
Raisler, Brian J. ;
Ambati, Jayakrishna .
NATURE, 2006, 443 (7114) :993-997
[6]   Chloramphenicol Eye Drops: An Old Dog in a New House [J].
Andaluz-Scher, Laura ;
Medow, Norman B. .
OPHTHALMOLOGY, 2020, 127 (10) :1289-1291
[7]   Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium [J].
Arafa, Mona G. ;
Girgis, Germeen N. S. ;
El-Dahan, Marwa S. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 :1335-1347
[8]   Electrohydrodynamic atomization and spray-drying for the production of pure drug nanocrystals and co-crystals [J].
Arzi, Roni Sverdlov ;
Sosnik, Alejandro .
ADVANCED DRUG DELIVERY REVIEWS, 2018, 131 :79-100
[9]   Better visual outcome at 1 year with antivascular endothelial growth factor treatment according to treat-and-extend compared with pro re nata in eyes with neovascular age-related macular degeneration [J].
Aurell, Sandra ;
Sjovall, Kersti ;
Paul, Anna ;
Moren, Asa ;
Granstam, Elisabet .
ACTA OPHTHALMOLOGICA, 2019, 97 (05) :519-524
[10]   Principles of pharmacology in the eye [J].
Awwad, Sahar ;
Ahmed, Abeer H. A. Mohamed ;
Sharma, Garima ;
Heng, Jacob S. ;
Khaw, Peng T. ;
Brocchini, Steve ;
Lockwood, Alastair .
BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (23) :4205-4223